Physician profile
Taylor August Robertson
NPI 1639559255
$2,770.80
in general payments reported to CMS, 2019-2025
13 companies · $52.94 in 2025
The $52.94 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $91.50 · 2021: $236 · 2022: $1,609 · 2023: $62.00 · 2024: $38.08 · 2025: $52.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,391.82 | 2022 | |
| Alon Medical Technology | $525.00 | 2019 | |
| Smith+Nephew, INC. | $357.39 | 2019-2022 | |
| Stryker Corporation | $215.60 | 2019-2025 | Ortholoc 2 Lapifuse |
| Convatec INC. | $62.00 | 2023 | |
| Paratek Pharmaceuticals, INC. | $38.48 | 2022 | |
| Treace Medical Concepts, INC. | $38.08 | 2024 | |
| Wright Medical Technology, INC. | $33.71 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $31.58 | 2020 | |
| Averitas Pharma INC. | $29.43 | 2025 | Qutenza |
| Merck Sharp & Dohme LLC | $16.81 | 2019 | |
| Arthrosurface Incorporated | $15.98 | 2019 | |
| Kerecis Limited | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.